China Pharma Outsourcing Market By 2015
Product Description
In the last eight years Chinese pharmaceutical outsourcing industry has grown in an astonishing rate of 48% each year. The country has become one of the primary choices of outsourcing destination for pharma/biotech companies around the world.
Supported with a vast amount of data (38 tables, 26 figures and 52 case studies), the report is by far the most comprehensive report about the Chinese pharma outsourcing industry and its market. It contains our in-depth analysis of current service capability and market size in each service sector as well as the most popular outsourcing models in China. In addition, the report also depicts a clear picture of future growth and development potential of this Chinese industry including the in-depth analysis of the growth drivers and resistors. It gives you a clear picture of the current state of this Chinese industry and what it will look like in the near future.
Note:
When this report is ordered, another report, “China Pharma Outsourcing Annual Review 2009”, also published by JZMed, Inc. and worth $985, will be given for free of charge.
Supported with a vast amount of data (38 tables, 26 figures and 52 case studies), the report is by far the most comprehensive report about the Chinese pharma outsourcing industry and its market. It contains our in-depth analysis of current service capability and market size in each service sector as well as the most popular outsourcing models in China. In addition, the report also depicts a clear picture of future growth and development potential of this Chinese industry including the in-depth analysis of the growth drivers and resistors. It gives you a clear picture of the current state of this Chinese industry and what it will look like in the near future.
Note:
When this report is ordered, another report, “China Pharma Outsourcing Annual Review 2009”, also published by JZMed, Inc. and worth $985, will be given for free of charge.